LA JOLLA, Calif., Aug. 20, 2017 /PRNewswire/ -- Tom Wamberg, one of the nation's foremost
experts on employee benefits and insurance, today announced the
formation of Wamberg Genomic Advisors (WGA). WGA advises employers,
employee benefit brokers, and life insurance companies, enabling
them to create programs that provide employees and policyholders
with easy access to affordable genomic tests.
Genomics is the study of the structure and function of genomes,
including all of an individual's genes. In contrast, genetics
focuses on the variation and function of single or limited numbers
of genes within a genome. In the context of human health, genomics
seeks to identify the interrelation of factors beyond genes, which
can lead to a deeper understanding of the risk of disease,
resulting in more effective preventive measures or treatments.
Genetics looks for specific mutations or variations within genes,
rather than the entire genome. While genetics provides important
information in understanding a person's health status or risk for
certain diseases or conditions, the information that can be learned
from examining an entire genome is broader.
"Knowledge of a person's genome is enabling medical
professionals to develop personalized health strategies,
treatments, and care paths that can be used to better manage or
prevent disease and enhance health and longevity," said Wamberg.
"When patients are empowered with this knowledge, they can become
more actively engaged in managing their own health and make better
decisions. As more people have their genome sequenced and analyzed,
the medical and health care communities are better equipped to
provide deeper insights into risk and disease, and make new medical
discoveries.
"Our mission is to help drive the genomic revolution by making
genomic testing readily accessible and affordable for everyone,"
added Wamberg. "The most promising avenues for widespread delivery
of genomic testing are employee benefit programs and life insurance
policies."
For more than three decades, Wamberg has developed innovative
benefit and financial strategies for employers of all sizes, from
emerging growth companies to the Fortune 100, as well as life
insurance companies. Before starting WGA, Wamberg was chairman and
CEO of Clark Consulting, a leader in the executive benefits space.
In addition to serving as CEO of WGA, Wamberg is chairman of Uniphy
Health LLC, which he co-founded, and a member of the Board of
Trustees of Cleveland Clinic.
WGA will focus initially on the following types of genomic
products and services:
Whole genome sequencing and reporting. The most
comprehensive method for analyzing the genome
Exome sequencing and reporting. Information on all the
genes that express proteins in a genome
Cancer genomic profiling. Sequencing of a cancer tumor to
learn about coding mutations that contribute to tumor
progression
Cancer liquid biopsy. Blood test that today can be used
in limited circumstances to detect cancer genomic material
circulating in the blood, such as when sufficient tumor material is
unavailable
Lifetime stem cell banking. Stem cells gathered at birth
to serve as a source of cellular material for the treatment of
conditions throughout a person's life
Lifetime connectivity to one's DNA. Information and
updates on variations in a person's genome when compared against
constantly updated genomic databases
About Wamberg Genomic Advisors
Wamberg Genomic Advisors (WGA) is your partner in the Genomic
Revolution. Our mission to make genomic testing readily available
at prices everyone can afford. Our focus is on delivering genomic
products and services to employers and their employees via their
trusted benefit brokers, and policyholders of life insurance
companies. To discover more about WGA and the future of genomics,
visit wamberggenomic.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/wamberg-genomic-advisors-launched-to-provide-easy-access-to-affordable-genomic-testing-300506867.html
SOURCE Wamberg Genomic Advisors